NUCLEIC ACID INSIGHTS

May 2026 Issue

Volume 3 Issue 4

Nucleic Acid Insights Volume 3 Issue 4
Download PDF

Featuring

Issue Spotlight: Achieving tissue-specific targeting and delivery
Other articles
Webinar

SPOTLIGHT

Achieving tissue-specific targeting and delivery

Expert Insight

Under the radar in siRNA therapeutics

Under the radar in siRNA therapeutics

Hunter Warren, Mehran Nikan
9 June
Read

Review

Polypeptide nanoparticles: a clinically validated, versatile delivery platform for RNA therapeutics

Polypeptide nanoparticles: a clinically validated, versatile delivery platform for RNA therapeutics

Fai Poon, Weixiong Zhong, Weiwei Tian
9 June
Read

Interview

Programmable RNA therapeutics: from intracellular sensing to cell-specific delivery

Programmable RNA therapeutics: from intracellular sensing to cell-specific delivery

Charannya Sozheesvari Subhramanyam
28 May
Read

articles

Editorial

Exploring the future of nucleic acid therapeutics: expert perspectives from the Nucleic Acid Insights Editorial Advisory Board

Exploring the future of nucleic acid therapeutics: expert perspectives from the Nucleic Acid Insights Editorial Advisory Board

Jokubas Leikauskas
9 June
Read

Innovator Insight

Selective removal of immunogenic double-stranded RNA from mRNA feeds using affinity chromatography

Selective removal of immunogenic double-stranded RNA from mRNA feeds using affinity chromatography

Nathaniel Clark
28 May
Read

Infographic

The industry speaks: assessing the state of oligonucleotide manufacturing in 2026

The industry speaks: assessing the state of oligonucleotide manufacturing in 2026

27 May
Read

Interview

Decoding mRNA stability: from endogenous decay pathways to therapeutic design

Decoding mRNA stability: from endogenous decay pathways to therapeutic design

Khalid SA Khabar
2 June
Read

Industry Insights

Industry Insights: Advancing oligonucleotide therapeutics through regulatory approvals, clinical data, and AI-enabled discovery

Industry Insights: Advancing oligonucleotide therapeutics through regulatory approvals, clinical data, and AI-enabled discovery

Jokubas Leikauskas
23 June
Read

Webinars